theranos Logo (WIPO, 16.12.2013)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke theranos wurde als Bildmarke am 16.12.2013 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Kreise #Kreise mit dunklen Flächen oder Teilen von Flächen
| Markenform | Bildmarke |
| Aktenzeichen | 1215596 |
| Länder | 
|
| Basismarke |
Nr. 85960709,
14. Juni 2013
|
| Anmeldedatum | 16. Dezember 2013 |
| Ablaufdatum | 19. März 2018 |
Markeninhaber
Markenvertreter
801 California Street,
Silicon Valley Center
US
Waren und Dienstleistungen
01
Reagents for scientific or research use; diagnostic reagents
for clinical or medical laboratory use (terms too vague in
the opinion of the International Bureau - Rule 13(2)(b) of
the Common Regulations); chemical preparations for
scientific purposes; reagents for chemical analysis;
diagnostic kits (terms too vague in the opinion of the
International Bureau - Rule 13(2)(b) of the Common
Regulations); testing kits containing reagents used in
analyzing and detecting certain toxins for clinical or
medical laboratory use; genetic identity tests comprised of
reagents; antibodies for in vitro scientific or research
use; biochemicals (terms too vague in the opinion of the
International Bureau - Rule 13(2)(b) of the Common
Regulations); biomedical compounds (terms too vague in the
opinion of the International Bureau - Rule 13(2)(b) of the
Common Regulations); chemical preparations to be used in
biochemical and clinical research; diagnostic preparations
for clinical or medical laboratory use (terms too vague in
the opinion of the International Bureau - Rule 13(2)(b) of
the Common Regulations)
05
Biological and chemical preparations for medical or
veterinary use; reagents and media for medical or veterinary
purposes; clinical medical reagents; biological and chemical
preparations, namely, antibodies for clinical, medical or
veterinary use to detect and analyze substances; diagnostic
kits for medical or veterinary use (terms too vague in the
opinion of the International Bureau - Rule 13(2)(b) of the
Common Regulations); diagnostic preparations for medical or
veterinary purposes; testing kits for testing bodily fluids
(terms too vague in the opinion of the International Bureau
- Rule 13(2)(b) of the Common Regulations); medical
diagnostic test kits comprised of reagents and assays for
testing of body fluids; medical diagnostic and monitoring
test strips for use in the treatment of a wide variety of
diseases and health disorders; test strips for medical and
laboratory analysis of blood; ovulation test kits (terms too
vague in the opinion of the International Bureau - Rule
13(2)(b) of the Common Regulations); biological tissue
cultures for medical or veterinary purposes; culture media
for cultivating blood cells
09
Computer software; computer software for medical monitoring
and analysis of medical data; computer software for analysis
of body fluids; computer software for communication and data
transfer between health care professionals and patients;
computer hardware; mobile electronic devices (terms too
vague in the opinion of the International Bureau - Rule
13(2)(b) of the Common Regulations); electronic
publications
10
Medical devices; medical devices, namely, point of care and
handheld devices for analysis of drugs, proteins and other
substances, and wireless transfer of medical data; medical
measuring apparatus; medical measuring apparatus, namely,
cartridges for use with therapies or equipment for medical
monitoring and analysis of substances; apparatus for blood
analysis; apparatus for taking blood samples; blood testing
apparatus; apparatus for clinical diagnosis; capillary
reagent tubes; capillary tubes for blood; capillary tubes
for samples; containers especially made for processing blood
samples; containers for medical waste; devices for
monitoring blood sugar; diagnostic apparatus for the
detection of a wide variety of diseases; health monitoring
devices; medical diagnostics apparatus; medical apparatus
and instruments for monitoring blood properties; medical
devices for obtaining body fluid samples; patient medical
monitors for monitoring a wide variety of physical
conditions and diseases; home or portable monitors for
monitoring a wide variety of physical conditions and
diseases
35
Administering pharmacy reimbursement programs and services;
administration of patient reimbursement programs; billing;
compiling of information into computer databases; management
and compilation of computerized databases; medical referrals
(terms too vague in the opinion of the International Bureau
- Rule 13(2)(b) of the Common Regulations); physician
referrals (terms too vague in the opinion of the
International Bureau - Rule 13(2)(b) of the Common
Regulations); medical billing support services; providing an
internet-based database of patient medical information
designed to facilitate sharing and maintenance of patient
medical information between and amongst the patient,
insurers and healthcare professionals providing services to
the patient; providing an internet-based system for
confirming patient identity, eligibility and authorization
for health insurance or medicare/medicaid services;
maintaining patient medical records and files
36
Insurance claims processing; pharmaceutical benefit
management services; pharmacy benefit management services;
medical laboratory benefit management services
39
Biomedical services, namely, storage of medical data;
biomedical services, namely, the storage of human cells for
medical use; consulting services in the field of air medical
operations in the nature of air medical transport; medical
transport services; transportation of medical waste and
special waste
42
Medical and scientific research services in the fields of
blood analysis health care and health care monitoring;
pharmaceutical research services; pharmaceutical research
and development; blood analysis services; chemical
laboratories; consulting services in the fields of
biotechnology, pharmaceutical research and development,
laboratory testing, diagnostics, and pharmacogenetics;
genetic testing of laboratory animals for research purposes;
biological research; biomedical research; laboratory
research in the field of chemistry, biochemistry, biology,
health and medicine; laboratory services, namely, pigment
and color analysis; laboratory services, namely, imaging
core lab services; medical laboratories (terms too vague in
the opinion of the International Bureau - Rule 13(2)(b) of
the Common Regulations); medical laboratory services (terms
too vague in the opinion of the International Bureau - Rule
13(2)(b) of the Common Regulations); providing laboratory
research services in the field of gene expression, namely,
cancer biology; rental of laboratory apparatus and
instruments; scientific laboratory services; providing a web
site featuring technology that enables patients, physicians
and other healthcare providers to generate, manage and
exchange medical information (terms too vague in the opinion
of the International Bureau - Rule 13(2)(b) of the Common
Regulations); Software as a Service (SaaS) for medical and
disease analysis
44
Medical evaluation services; medical evaluation services,
namely, assessment of patients undergoing medical treatment;
medical monitoring services; medical monitoring services,
namely, monitoring the efficacy of therapy and total patient
or consumer health; medical diagnostic testing, monitoring
and reporting services; collection and preservation of human
and animal blood; consulting services in the field of
health; consulting services in the field of diagnostic
medical testing; consulting services in the fields of health
and healthcare; drug use testing services; drug, alcohol and
DNA screening for medical purposes; health assessment
services; health care; medical counseling; medical
information; medical screening; medical services; medical
testing for diagnostic or treatment purposes; providing
information in the field of pet health; pet hospital
services; providing a web site featuring medical information
(terms too vague in the opinion of the International Bureau
- Rule 13(2)(b) of the Common Regulations); providing a
website featuring health and healthcare information;
internet-based health care information services; providing
health information; providing healthcare information; rental
of medical equipment; veterinary special services; medical
and veterinary services; biomedical services; advisory,
consultative and telephone helpline services relating to the
use of apparatus, instruments and test kits diagnostic
testing, self testing, self monitoring and testing for
adverse drug reactions
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 21. September 2018 | 2018/42 Gaz | US | RAW: Total Ceasing Effect |
| 13. Juni 2018 | 2018/38 Gaz | MX | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 25. April 2018 | 2018/21 Gaz | PH | Ablehnung |
| 19. Mai 2017 | 2017/32 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 03. November 2016 | 2017/20 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 07. April 2016 | 2016/17 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 05. April 2016 | 2016/22 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 28. März 2016 | 2016/26 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 12. Januar 2016 | 2016/3 Gaz | IL | Ablehnung |
| 12. Oktober 2015 | 2015/42 Gaz | IN | Ablehnung |
| 06. Oktober 2015 | 2015/43 Gaz | RAW: Limitation | |
| 07. September 2015 | 2015/38 Gaz | RU | Ablehnung |
| 26. August 2015 | 2015/35 Gaz | AU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 18. August 2015 | 2015/35 Gaz | KR | Ablehnung |
| 13. August 2015 | 2015/33 Gaz | CH | Ablehnung |
| 28. Juli 2015 | 2015/31 Gaz | MX | Ablehnung |
| 24. Juli 2015 | 2015/33 Gaz | CN | Ablehnung |
| 20. März 2015 | 2015/13 Gaz | NO | Ablehnung |
| 05. Februar 2015 | 2015/6 Gaz | JP | Ablehnung |
| 27. Januar 2015 | 2015/5 Gaz | KR | Ablehnung |
| 09. Januar 2015 | 2015/4 Gaz | SG | Ablehnung |
| 04. Dezember 2014 | 2014/51 Gaz | PH | Ablehnung |
| 03. November 2014 | 2014/45 Gaz | AU | Ablehnung |
| 16. Dezember 2013 | 2014/35 Gaz | US | Eintragung |
ID: 141215596